Cassady Schiller Wealth Management, LLC Axsome Therapeutics, Inc. Transaction History
Cassady Schiller Wealth Management, LLC
- $268 Million
- Q4 2024
A detailed history of Cassady Schiller Wealth Management, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Cassady Schiller Wealth Management, LLC holds 15 shares of AXSM stock, worth $1,684. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15Holding current value
$1,684% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
360Shares Held
36.4MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$455 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$438 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$371 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$165 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$156 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.81B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...